Citigroup’s Elanco Animal Health ELAN Stock Holding History

Citigroup’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-45,000	Closed	-$545K	–	5682
2024 Q4	$545K	Hold	45,000	–	–	﹤0.01%	3759
2024 Q3	$661K	Buy	+45,000	New	+$627K	﹤0.01%	3553
2024 Q2	–	Sell	-29,400	Closed	-$479K	–	5624
2024 Q1	$479K	Buy	+29,400	New	+$460K	﹤0.01%	3606
2023 Q4	–	Sell	-30,000	Closed	-$337K	–	5742
2023 Q3	$337K	Hold	30,000	–	–	﹤0.01%	3342
2023 Q2	$302K	Buy	+30,000	New	+$278K	﹤0.01%	3676
2021 Q1	–	Sell	-20,900	Closed	-$641K	–	6546
2020 Q4	$641K	Buy	20,900 +8,900	+74%	+$272K	﹤0.01%	3984
2020 Q3	$335K	Sell	12,000 -67,200	-85%	-$1.7M	﹤0.01%	4203
2020 Q2	$1.7M	Sell	79,200 -55,900	-41%	-$1.23M	﹤0.01%	3002
2020 Q1	$3.02M	Buy	135,100 +132,900	+6,041%	+$3.64M	﹤0.01%	2095
2019 Q4	$65K	Buy	2,200 +200	+10%	+$5.43K	﹤0.01%	6106
2019 Q3	$53K	Sell	2,000 -8,100	-80%	-$243K	﹤0.01%	6086
2019 Q2	$341K	Sell	10,100 -11,200	-53%	-$364K	﹤0.01%	4805
2019 Q1	$683K	Buy	+21,300	New	+$655K	﹤0.01%	3833

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Citigroup's ELAN Position: Q1 2026 in Review

Citigroup reduced its Elanco Animal Health (ELAN) stake by 28% in Q1 2026, selling an estimated $2.1M and leaving 220,452 shares worth $5.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1929.

Citigroup first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $50.7M in Q1 2019. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

Citigroup held 220,452 shares of Elanco Animal Health worth $5.28M as of Q1 2026.
Citigroup sold 85,723 Elanco Animal Health shares in Q1 2026, an estimated $2.1M.
Elanco Animal Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #1929 holding.
Citigroup first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
Citigroup's Elanco Animal Health position peaked at $50.7M in Q1 2019.
515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.